Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > MAJOR, MAJOR KICK IN THE GROIN!
View:
Post by ISAloser247 on Apr 24, 2010 1:28pm

MAJOR, MAJOR KICK IN THE GROIN!




....remember when T-shirt Bob , in the POWERHOUSE article mentioned that "the Big Boys have abandoned

transplantation"?  well,.....


APRIL 22, 2010  NOVARTIS RECEIVES FDA APPROVAL FOR ZORTRESS, A NEW OPTION FOR PREVENTING

ORGAN REJECTION, PRESERVING KIDNEY FUNCTION.,   in oral form!


HAVE TO PUT ON SOME SHADES, CAUSE THE FUTURE LOOKS SO BRIGHT!

.....SOMEONE IN ISA CORPORATE, SHOULD FIND SOME MORE BANDWIDTH, DO A LITTLE HOMEWORK

ON THE BIG BOYS!  OH, WONDER WHY PROFESSIONAL11 DID NOT INFORM US OF THIS NEWS?

IT IS OBVIOUSLY USELESS , POINTLESS INFORMATION AND HAS ABSOLUTELY NO BEARING ON THE

FUTURE OF ISOTECHNIKA!!!!!!!!   








Comment by labumba on Apr 24, 2010 2:53pm
Major, major kick in the groin ?......not quite.....Zortress is not the first line of defense in terms of immunosuppression...it still needs to combine with Cyclosporin in a drug therapy to treat patients after the critical acute organ rejection period.......it is an enhance drug for a long term treatment for kidney transplanted patients-------------------------------------------------- " ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities